Reports Algiax Pharmaceuticals Announces Positive Phase 2a Results for AP-325 in Neuropathic Pain Reports Algiax Pharmaceuticals, a clinical-stage biotechnology company dedicated to developing innovative therapies for chronic neuropathic pain, has announced compelling topline results from its Reports Phase 2a proof-of-concept…
Cosette Pharmaceuticals a leading specialty pharmaceuticals company, has announced the appointment of Brad Leonard as Vice President, Generics Commercial Operations. This strategic move comes as the company continues its expansion in the generics market, reinforcing its commitment to leadership excellence…
Bayer has officially submitted a marketing authorization application to the European Medicines Agency (EMA), seeking approval for the use of finerenone in adult patients with heart failure (HF) with a left ventricular ejection fraction (LVEF) of 40% or greater. This…
Inhalon Biopharma a clinical-stage biotechnology company focused on developing innovative treatments for acute respiratory infections (ARI), has announced a major milestone in the advancement of its inhaled antibody platform. The company has successfully completed Investigational New Drug (IND)-enabling studies for…
Ethris Reports Promising Phase 1 Data for mRNA Candidate ETH47 in Asthma Ethris GmbH, a pioneering biotechnology company specializing in next-generation RNA therapeutics and vaccines, has unveiled encouraging topline data from the completed Phase 1 clinical trial of its lead…
40 Years of Excellence in Laser Technology Quanta System proudly celebrates a major milestone in 2025-40 years of pioneering innovation in laser technology. Since its founding in 1985, it has been at the forefront of developing cutting-edge laser solutions for…
Enveric Biosciences Secures Patent Protection for Breakthrough Neuroplastogen EB-003 In a significant milestone for its innovative drug development pipeline, Enveric Biosciences (NASDAQ: ENVB) has announced the receipt of a Notice of Allowance (NOA) from the United States Patent and Trademark…
RevBio Secures 10th Patent for TETRANITE®: Expanding Protection for Revolutionary Bone Adhesive Technology In a significant milestone for regenerative medicine, ITS, a clinical-stage medical device company, has been granted its 10th U.S. patent for its groundbreaking TETRANITE® bone adhesive technology.…
The global Pharmaceutical R&D Outsourcing market is set to grow significantly, with a valuation of USD 84.01 billion in 2023 and expected to reach USD 150.04 billion by 2029, representing a compound annual growth rate (CAGR) of 10.15%. This growth…
Modella AI, a leader in generative and agentic artificial intelligence for biomedicine, has announced that its advanced generative AI co-pilot, PathChat DX, has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA). This prestigious recognition highlights…
Trilobio Unveils Revolutionary Whole-Lab Automation Platform at SLAS2025: A Game-Changer for Life Science Research San Diego, CA – January 25-29, 2025 – Trilobio, a pioneering developer of whole-laboratory automation solutions, is set to make waves at the Society for Laboratory…
Inventia Life Science Unveils RASTRUM™ Allegro to Transform 3D Cell Culture in Drug Discovery and Disease Research Inventia Life Science, a leader in 3D cell culture technologies, has announced the launch of RASTRUM™ Allegro, a revolutionary platform that enhances drug…